Nance S, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.Search in Google Scholar
Meny GM, Flickinger C, Marcucci CJ. The American Rare Donor Program. Crit Care 2013;28:110.e9–18. doi:10.1016/j.jcrc.2012.02.017.Search in Google Scholar
Keller MA, Nance ST, Kavitsky V et al. The American Rare Donor Program: twenty-five years supporting rare blood needs. Immunohematology In press.Search in Google Scholar
Maurer J, Nance S, Kavitsky V, Facey D, Keller M. High prevalence antigen negative unit requests: what if it includes being O negative? Transfusion 2021;35(Suppl 3):159–60A.Search in Google Scholar
Maurer J, Nance S, Kavitsky V, Facey D, Keller M . When rare blood goes overseas. Transfusion 2021;35(Suppl 3):80A.Search in Google Scholar
Makroo R, Gupta R, Bhatia A, et al. Rh phenotype, allele and haplotype frequencies among 51,857 blood donors in North India. Blood Tranfus 2014;12:36–9.Search in Google Scholar
